(3-((2-(Piperidin-1-yl)ethyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

2-(2,5-Dimethylbenzoyl)-5-(1,3-dioxolan-2-yl)thiophene, 97.0%, 1g

Objetivo IOS Plan PLi S100x/1.25 de inmersión en aceite con corrección infinita. Distancia de trabajo 0,36 mm

3-(4-Bromophenyl)prop-2-ynoic acid, 98% GC, 100mg

1-([(TERT-BUTOXY)CARBONYL]AMINO)-2-METHYLCYCLOBUTANE-1-CARBOXYLIC ACID, 95%, 500mg

Tridecylamine (=Monotridecylamine) (mixture of branched chain isomers)>98.0%(T)500mL

(3S,3'S)-4,4'-(7-Chloropyrido[2,3-d]pyrimidine-2,4-diyl)bis(3-methylmorpholine), 95.0%, 250mg

Monomethyl trans-1,4-Cyclohexanedicarboxylate>97.0%(GC)(T)25g

4-(Methylamino)-1-(pyridin-3-yl)butan-1-one dihydrochloride, 97%, 100mg

{[3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}amine, 95.0%, 25g

4-Fluoro-2-(hydroxymethyl)phenol, 97%, 100mg

3-Iodo-2-methoxypyridine, 95.0%, 5g

6-BROMO-2-METHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 250mg